Evidence map›Paper›PMID 35840781›Full record

ArticleCommunications biology2022

Structure-based rational design of an enhanced fluorogen-activating protein for fluorogens based on GFP chromophore.

Marina V Goncharuk, Nadezhda S Baleeva, Dmitry E Nolde, Alexey S Gavrikov, Alexey V Mishin, Alexander S Mishin, Andrey Y Sosorev, Alexander S Arseniev, Sergey A Goncharuk, Valentin I Borshchevskiy and 3 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Reversible, Chemically Gated FRET via Ligand-Activated Acceptors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A multi-colour fluorogenic tag and its application inMicrobiology (Reading, England) · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Marina V Goncharuk *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.
Nadezhda S Baleeva *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.
Dmitry E NoldeShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.ORCID 0000-0002-3328-0024
Alexey S GavrikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.
Alexey V MishinMoscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia.ORCID 0000-0003-3759-380X
Alexander S MishinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.ORCID 0000-0002-4935-7030
Andrey Y SosorevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.ORCID 0000-0001-9343-5502
Alexander S ArsenievShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.
Sergey A GoncharukShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.ORCID 0000-0002-0263-6462
Valentin I BorshchevskiyMoscow Institute of Physics and Technology, Dolgoprudny, 141701, Russia.ORCID 0000-0003-4398-9712
Roman G EfremovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia.
Konstantin S MineevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia. mineev@nmr.ru.ORCID 0000-0002-2418-9421
Mikhail S BaranovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, 117997, Russia. baranovmikes@gmail.com.ORCID 0000-0002-9339-7603
Institute of Bioorganic Chemistry · RUMoscow Institute of Physics and Technology · RUNational Research University Higher School of Economics · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Fluorescence-Activating and absorption-Shifting Tag" (FAST) is a well-studied fluorogen-activating protein with high brightness and low size, able to activate a wide range of fluorogens. This makes FAST a promising target for both protein and fluorogen optimization. Here, we describe the structure-based rational design of the enhanced FAST mutants, optimized for the N871b fluorogen. Using the spatial structure of the FAST/N871b complex, NMR relaxation analysis, and computer simulations, we identify the mobile regions in the complex and suggest mutations that could stabilize both the protein and the ligand. Two of our mutants appear brighter than the wild-type FAST, and these mutants provide up to 35% enhancement for several other fluorogens of similar structure, both in vitro and in vivo. Analysis of the mutants by NMR reveals that brighter mutants demonstrate the highest stability and lowest length of intermolecular H-bonds. Computer simulations provide the structural basis for such stabilization.

Indexed as

Fluorescent DyesProteinsFluorescenceFluorescent DyesProteins

Identifiers

PMID35840781
PMCPMC9287381
OpenAlexW4285594360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.